Collette Health Appoints Christine Gall as Chief Nursing Officer

Christine Gall

Collette Health, a leading provider of virtual patient observation solutions, is pleased to announce the appointment of healthcare visionary Christine Gall DrPH, MS, BSN, as chief nursing officer. In this role, she will oversee all clinical operations and innovation initiatives to further enhance Collette Health’s commitment to helping hospitals integrate virtual patient safety solutions to prevent falls and adverse events and improve patient outcomes.

Experience

Christine Gall brings three decades of experience and a wealth of knowledge in Patient Safety and Engagement, Quality, and Public Health Leadership. Throughout her career, she has leveraged her clinical and leadership expertise to develop new services and programs that address gaps in access and service delivery for at risk and vulnerable patient populations. Gall’s passion for improving healthcare quality, safety, and outcomes has enabled her to sharpen her leadership expertise in a variety of roles and environments spanning the continuum of care and in dozens of care delivery settings.

“I’m thrilled to be joining Collette Health at such a pivotal time as we see the role of clinicians evolve and new technology transform the healthcare industry,” said Gall. “I am eager to join a team that’s driving positive patient outcomes, improving clinical workflows, and helping to reshape the healthcare landscape as hospitals face major challenges that are driving novel care delivery strategies. I look forward to ensuring clinicians have the resources and support needed to thrive in their professional practice and to provide the highest level of care to their patients.”

Educational Background

Gall received her Doctoral Degree in Public Health Leadership (DrPH), from the University of Illinois, Chicago, her Master of Science Degree in Healthcare Management (MS) from the University of Wisconsin-Milwaukee School of Business Administration, and a Bachelor of Nursing Degree (BSN), from the University of Wisconsin-Milwaukee School of Nursing.

Throughout her career, Gall has focused on addressing emerging industry problems and expanding programs to identify gaps and meet the evolving needs in the healthcare sector. She is recognized for her authentic and results-oriented leadership. In her new role, she will collaborate with Collette Health’s product and clinician-led teams to apply human-centered AI to bring new use cases to life.

Holly Miller, president of Collette Health

“Christine’s passion for improving healthcare, coupled with her mission-driven focus on quality and safety, will greatly benefit our team and patients. Her extensive clinical expertise and diverse background makes her an invaluable asset. With her guidance, we’ll continue driving innovation and incorporating crucial clinician feedback for success.”

Collette Health, now rated in Best in KLAS in the virtual sitting and nursing category, remains committed to driving innovation with its virtual patient observation solutions that include persistent two-way video and audio, a 12:1 patient-to-observer ratio, and on-staff virtual observers.

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”